719
Views
4
CrossRef citations to date
0
Altmetric
Clinical Studies

Comparison of clinical characteristics between automated peritoneal dialysis and continuous ambulatory peritoneal dialysis: a 2-year single-center observational study

, , , , , , & show all
Pages 817-824 | Received 13 Mar 2010, Accepted 11 May 2010, Published online: 21 Jul 2010

REFERENCES

  • Lameire NH. The impact of residual renal function on the adequacy of peritoneal dialysis. Nephron. 1997;77:14–28.
  • Moist LM, Port FK, Orzol SM, Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556–564.
  • Jansen MA, Hart AA, Korevaar JC, Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62:1046–1053.
  • CANUSA Peritoneal Dialysis Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol. 1996;7:198–207.
  • Bargman JM, Thorpe KE, Churchill DN. For the CANUSA Peritoneal Dialysis Study Group. The importance of residual renal function for survival in patients on peritoneal dialysis. J Am Soc Nephrol. 1997;8:185A (Abstract).
  • Hiroshige K, Yuu K, Soejima M, Rapid decline of residual renal function in patients on automated peritoneal dialysis. Perit Dial Int. 1996;16:307–315.
  • Hufnagel G, Michel C, Queffeulou G, The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant. 1999;14:1224–1228.
  • Holley JL, Bernardini J, Piraino B. Continuous cycling peritoneal dialysis is associated with lower rates of catheter infections than continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1990;16:133–136.
  • Brunkhorst R, Wrenger E, Krautzig S, Clinical experience with home automated peritoneal dialysis. Kidney Int. 1994;46(Suppl. 48):S25–30.
  • Korbet SM, Vonesh EF, Firanek CA. Peritonitis in an urban peritoneal dialysis program: An analysis of infecting pathogens. Am J Kidney Dis. 1995;26:47–53.
  • Rodríguez-Carmona A, Pérez Fontán M, García Falcón T, A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis. Perit Dial Int. 1999;19:253–258.
  • Rodby RA, Firanek CA, Cheng YG, Reproducibility of studies of peritoneal dialysis adequacy. Kidney Int. 1996;50:267–271.
  • Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12:2158–2162.
  • Kieman L, Kliger A, Gorban-Brennan N, Comparison of continuous ambulatory peritoneal dialysis-related infections with different ‘Y-tubing’ exchange systems. J Am Soc Nephrol. 1995;5:1835–1837.
  • Rabindranath KS, Adams J, Ali TZ, Automated vs continuous ambulatory peritoneal dialysis: A systematic review of randomized controlled trials. Nephrol Dial Transplant. 2007;22:2991–2998.
  • Singhal MK, Bhaskaran S, Vidgen E, Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int. 2000;20:429–438.
  • Lysaght MJ, Vonesh EF, Gotch F, The influence of dialysis treatment modality on decline of remaining renal function. ASAIO Trans. 1991;37:598–604.
  • Brenner BM, Cooper ME, de Zeeuw D, Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861–869.
  • Mora-Macia J, Cases A, Calero F, Effect of angiotensin II receptor blockade on renal disease progression in patients with non-diabetic chronic renal failure. Nephrol Dial Transplant. 2001;16:82–84.
  • Li PK, Chow KM, Wong TY, Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med. 2003;139:105–112.
  • Suzuki H, Kanno Y, Sugahara S, Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis. 2004;43:1056–1064.
  • Akbari A, Knoll G, Ferguson D, Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis: Systematic review and meta-analysis of randomized controlled trials. Perit Dial Int. 2009;29:554–561.
  • Shin SK, Noh H, Kang SW, Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1999;19:138–142.
  • Port FK, Held PJ, Nolph KD, Risk of peritonitis and technique failure by CAPD connection technique. A national study. Kidney Int. 1992;42:967–974.
  • Alexander SR, Sullivan EK, Harmon WE, Maintenance dialysis in North American children and adolescents: A preliminary report. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Kidney Int. 1993;44(Suppl. 43):S104–109.
  • Lavender S, Hilton PJ, Jones NF. The measurement of glomerular filtration rate in renal disease. Lancet. 1969;2:1216–1219.
  • De Fijter CW, Oe LP, Nauta JJ, Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med. 1994;120:264–271.
  • Brunkhorst RR. Individualized PD prescription: APD versus CAPD. Perit Dial Int. 2005;25(Suppl. 3):S92–94.
  • Mehrotra R, Chiu YW, Kalantar-Zadeh K, The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int. 2009;76:97–107.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.